Rather, HDAC7 is a biomarker of favorable prognosis for infants with high-risk t(4;11) pro-B-ALL, and its overexpression confers a leukemia-suppressing phenotype in this set of patients. The gene discussed is HDAC7; the disease is acute lymphoblastic leukemia.